nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—ABCC10—Methotrexate—ankylosing spondylitis	0.0905	0.117	CbGbCtD
Docetaxel—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0645	0.0835	CbGbCtD
Docetaxel—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0612	0.0792	CbGbCtD
Docetaxel—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0583	0.0755	CbGbCtD
Docetaxel—SLCO1B3—Methotrexate—ankylosing spondylitis	0.0505	0.0654	CbGbCtD
Docetaxel—SLC22A7—Methotrexate—ankylosing spondylitis	0.0445	0.0576	CbGbCtD
Docetaxel—ABCC1—Methotrexate—ankylosing spondylitis	0.0349	0.0452	CbGbCtD
Docetaxel—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0323	0.0418	CbGbCtD
Docetaxel—ABCC2—Dexamethasone—ankylosing spondylitis	0.0322	0.0416	CbGbCtD
Docetaxel—ABCG2—Dexamethasone—ankylosing spondylitis	0.0291	0.0377	CbGbCtD
Docetaxel—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0277	0.0359	CbGbCtD
Docetaxel—ABCC2—Methotrexate—ankylosing spondylitis	0.0259	0.0335	CbGbCtD
Docetaxel—ABCG2—Methotrexate—ankylosing spondylitis	0.0234	0.0303	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0215	0.0278	CbGbCtD
Docetaxel—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0215	0.0278	CbGbCtD
Docetaxel—ABCB1—Betamethasone—ankylosing spondylitis	0.018	0.0233	CbGbCtD
Docetaxel—ABCB1—Prednisolone—ankylosing spondylitis	0.0178	0.023	CbGbCtD
Docetaxel—ABCB1—Prednisone—ankylosing spondylitis	0.0168	0.0217	CbGbCtD
Docetaxel—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0166	0.0215	CbGbCtD
Docetaxel—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0161	0.0209	CbGbCtD
Docetaxel—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0126	0.0163	CbGbCtD
Docetaxel—CYP3A4—Betamethasone—ankylosing spondylitis	0.0108	0.014	CbGbCtD
Docetaxel—CYP3A4—Prednisolone—ankylosing spondylitis	0.0107	0.0138	CbGbCtD
Docetaxel—ABCB1—Dexamethasone—ankylosing spondylitis	0.0105	0.0136	CbGbCtD
Docetaxel—CYP3A4—Prednisone—ankylosing spondylitis	0.0101	0.013	CbGbCtD
Docetaxel—ABCB1—Methotrexate—ankylosing spondylitis	0.00843	0.0109	CbGbCtD
Docetaxel—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00628	0.00813	CbGbCtD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.00219	0.0322	CbGpPWpGaD
Docetaxel—TUBB2B—Orphan transporters—ANO6—ankylosing spondylitis	0.00218	0.0322	CbGpPWpGaD
Docetaxel—TUBB6—Orphan transporters—ANO6—ankylosing spondylitis	0.00218	0.0322	CbGpPWpGaD
Docetaxel—TUBB3—Orphan transporters—ANO6—ankylosing spondylitis	0.00211	0.0311	CbGpPWpGaD
Docetaxel—TUBB2A—Orphan transporters—ANO6—ankylosing spondylitis	0.00204	0.0301	CbGpPWpGaD
Docetaxel—TUBB1—Orphan transporters—ANO6—ankylosing spondylitis	0.002	0.0294	CbGpPWpGaD
Docetaxel—TUBB4A—Orphan transporters—ANO6—ankylosing spondylitis	0.00179	0.0264	CbGpPWpGaD
Docetaxel—TUBB4B—Orphan transporters—ANO6—ankylosing spondylitis	0.00164	0.0242	CbGpPWpGaD
Docetaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.00158	0.0232	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00156	0.023	CbGpPWpGaD
Docetaxel—EGFR—EGFR Transactivation by Gastrin—MMP3—ankylosing spondylitis	0.00153	0.0225	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00145	0.0214	CbGpPWpGaD
Docetaxel—GHRHR—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00145	0.0213	CbGpPWpGaD
Docetaxel—TUBB8—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00119	0.0175	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—IL1R2—ankylosing spondylitis	0.00113	0.0166	CbGpPWpGaD
Docetaxel—BCL2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.00112	0.0165	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.00112	0.0165	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.001	0.0148	CbGpPWpGaD
Docetaxel—KIF11—Immune System—KIR3DL1—ankylosing spondylitis	0.000945	0.0139	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000895	0.0132	CbGpPWpGaD
Docetaxel—ABCC10—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000843	0.0124	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000723	0.0107	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000718	0.0106	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—IL1A—ankylosing spondylitis	0.000712	0.0105	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000671	0.00989	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.000629	0.00928	CbGpPWpGaD
Docetaxel—TUBB2B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000601	0.00886	CbGpPWpGaD
Docetaxel—TUBB6—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000601	0.00886	CbGpPWpGaD
Docetaxel—TUBB—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000596	0.00878	CbGpPWpGaD
Docetaxel—TUBB3—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00058	0.00856	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL1R2—ankylosing spondylitis	0.000573	0.00845	CbGpPWpGaD
Docetaxel—TUBB2A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000562	0.00829	CbGpPWpGaD
Docetaxel—TUBB1—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00055	0.0081	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000546	0.00805	CbGpPWpGaD
Docetaxel—KIF11—Immune System—ERAP1—ankylosing spondylitis	0.000543	0.00801	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000533	0.00786	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000533	0.00786	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000532	0.00784	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000525	0.00775	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000515	0.00759	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000514	0.00758	CbGpPWpGaD
Docetaxel—BCL2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000508	0.00749	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000499	0.00735	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CARD9—ankylosing spondylitis	0.000497	0.00732	CbGpPWpGaD
Docetaxel—TUBB4A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000493	0.00728	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000488	0.00719	CbGpPWpGaD
Docetaxel—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000451	0.00666	CbGpPWpGaD
Docetaxel—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—ankylosing spondylitis	0.000445	0.00656	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000438	0.00646	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.000408	0.00601	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0004	0.0059	CbGpPWpGaD
Docetaxel—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—ankylosing spondylitis	0.0004	0.0059	CbGpPWpGaD
Docetaxel—EGFR—a6b1 and a6b4 Integrin signaling—IL1A—ankylosing spondylitis	0.000398	0.00587	CbGpPWpGaD
Docetaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	0.000395	0.00583	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000392	0.00578	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000382	0.00563	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000381	0.00562	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000362	0.00533	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000342	0.00504	CbGpPWpGaD
Docetaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.000327	0.00482	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.00032	0.00471	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-C—ankylosing spondylitis	0.000312	0.0046	CbGpPWpGaD
Docetaxel—BCL2—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.000305	0.00449	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000304	0.00448	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000297	0.00438	CbGpPWpGaD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.000292	0.0043	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000282	0.00415	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000273	0.00403	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL1RN—ankylosing spondylitis	0.000271	0.004	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00027	0.00397	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—ankylosing spondylitis	0.000269	0.00397	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—TNF—ankylosing spondylitis	0.000264	0.0039	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000259	0.00382	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000256	0.00377	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KIR3DL1—ankylosing spondylitis	0.000247	0.00364	CbGpPWpGaD
Docetaxel—BCL2—Ceramide signaling pathway—TNF—ankylosing spondylitis	0.000242	0.00357	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000241	0.00355	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD79A—ankylosing spondylitis	0.000238	0.00351	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000225	0.00332	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CARD9—ankylosing spondylitis	0.000223	0.00328	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000216	0.00319	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000216	0.00319	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000213	0.00314	CbGpPWpGaD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—TNF—ankylosing spondylitis	0.000211	0.00311	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000209	0.00308	CbGpPWpGaD
Docetaxel—Myalgia—Triamcinolone—ankylosing spondylitis	0.000206	0.00129	CcSEcCtD
Docetaxel—Pneumonia—Methotrexate—ankylosing spondylitis	0.000205	0.00129	CcSEcCtD
Docetaxel—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000205	0.00129	CcSEcCtD
Docetaxel—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000205	0.00129	CcSEcCtD
Docetaxel—Eye disorder—Prednisone—ankylosing spondylitis	0.000205	0.00128	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000205	0.00302	CbGpPWpGaD
Docetaxel—Infestation—Methotrexate—ankylosing spondylitis	0.000204	0.00128	CcSEcCtD
Docetaxel—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000204	0.00128	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000204	0.00128	CcSEcCtD
Docetaxel—Flushing—Prednisone—ankylosing spondylitis	0.000204	0.00128	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000203	0.00127	CcSEcCtD
Docetaxel—TUBB2A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000202	0.00298	CbGpPWpGaD
Docetaxel—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000201	0.00126	CcSEcCtD
Docetaxel—Renal failure—Methotrexate—ankylosing spondylitis	0.000201	0.00126	CcSEcCtD
Docetaxel—Stomatitis—Methotrexate—ankylosing spondylitis	0.000199	0.00125	CcSEcCtD
Docetaxel—Angiopathy—Prednisone—ankylosing spondylitis	0.000199	0.00125	CcSEcCtD
Docetaxel—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000199	0.00124	CcSEcCtD
Docetaxel—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000198	0.00124	CcSEcCtD
Docetaxel—Immune system disorder—Prednisone—ankylosing spondylitis	0.000198	0.00124	CcSEcCtD
Docetaxel—TUBB1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000198	0.00292	CbGpPWpGaD
Docetaxel—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000197	0.00124	CcSEcCtD
Docetaxel—Oedema—Triamcinolone—ankylosing spondylitis	0.000197	0.00124	CcSEcCtD
Docetaxel—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000197	0.00123	CcSEcCtD
Docetaxel—Syncope—Dexamethasone—ankylosing spondylitis	0.000197	0.00123	CcSEcCtD
Docetaxel—Syncope—Betamethasone—ankylosing spondylitis	0.000197	0.00123	CcSEcCtD
Docetaxel—Arrhythmia—Prednisone—ankylosing spondylitis	0.000196	0.00123	CcSEcCtD
Docetaxel—Infection—Triamcinolone—ankylosing spondylitis	0.000196	0.00123	CcSEcCtD
Docetaxel—Infection—Methylprednisolone—ankylosing spondylitis	0.000196	0.00123	CcSEcCtD
Docetaxel—KIF11—Immune System—IL1A—ankylosing spondylitis	0.000195	0.00288	CbGpPWpGaD
Docetaxel—Shock—Triamcinolone—ankylosing spondylitis	0.000194	0.00122	CcSEcCtD
Docetaxel—Insomnia—Prednisolone—ankylosing spondylitis	0.000194	0.00122	CcSEcCtD
Docetaxel—Alopecia—Prednisone—ankylosing spondylitis	0.000194	0.00121	CcSEcCtD
Docetaxel—KIF11—Immune System—CD40LG—ankylosing spondylitis	0.000194	0.00286	CbGpPWpGaD
Docetaxel—Shock—Methylprednisolone—ankylosing spondylitis	0.000194	0.00121	CcSEcCtD
Docetaxel—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000193	0.00121	CcSEcCtD
Docetaxel—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000193	0.00121	CcSEcCtD
Docetaxel—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000193	0.00121	CcSEcCtD
Docetaxel—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000193	0.00121	CcSEcCtD
Docetaxel—Epistaxis—Methotrexate—ankylosing spondylitis	0.000193	0.00121	CcSEcCtD
Docetaxel—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000193	0.00121	CcSEcCtD
Docetaxel—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000193	0.00121	CcSEcCtD
Docetaxel—Mental disorder—Prednisone—ankylosing spondylitis	0.000192	0.0012	CcSEcCtD
Docetaxel—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000192	0.0012	CcSEcCtD
Docetaxel—GHRHR—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000192	0.00283	CbGpPWpGaD
Docetaxel—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000191	0.0012	CcSEcCtD
Docetaxel—Erythema—Prednisone—ankylosing spondylitis	0.000191	0.0012	CcSEcCtD
Docetaxel—Malnutrition—Prednisone—ankylosing spondylitis	0.000191	0.0012	CcSEcCtD
Docetaxel—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000191	0.00119	CcSEcCtD
Docetaxel—Convulsion—Dexamethasone—ankylosing spondylitis	0.00019	0.00119	CcSEcCtD
Docetaxel—Convulsion—Betamethasone—ankylosing spondylitis	0.00019	0.00119	CcSEcCtD
Docetaxel—Hypertension—Dexamethasone—ankylosing spondylitis	0.000189	0.00119	CcSEcCtD
Docetaxel—Hypertension—Betamethasone—ankylosing spondylitis	0.000189	0.00119	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000187	0.00276	CbGpPWpGaD
Docetaxel—Myalgia—Betamethasone—ankylosing spondylitis	0.000187	0.00117	CcSEcCtD
Docetaxel—Myalgia—Dexamethasone—ankylosing spondylitis	0.000187	0.00117	CcSEcCtD
Docetaxel—KIF11—Immune System—HLA-B—ankylosing spondylitis	0.000184	0.00272	CbGpPWpGaD
Docetaxel—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000184	0.00115	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000184	0.00271	CbGpPWpGaD
Docetaxel—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000184	0.00115	CcSEcCtD
Docetaxel—Pain—Prednisolone—ankylosing spondylitis	0.000183	0.00115	CcSEcCtD
Docetaxel—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000183	0.00115	CcSEcCtD
Docetaxel—Hepatitis—Methotrexate—ankylosing spondylitis	0.000183	0.00115	CcSEcCtD
Docetaxel—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000182	0.00114	CcSEcCtD
Docetaxel—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000181	0.00113	CcSEcCtD
Docetaxel—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00018	0.00113	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00018	0.00113	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000179	0.00112	CcSEcCtD
Docetaxel—Oedema—Dexamethasone—ankylosing spondylitis	0.000179	0.00112	CcSEcCtD
Docetaxel—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000179	0.00112	CcSEcCtD
Docetaxel—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000179	0.00112	CcSEcCtD
Docetaxel—Oedema—Betamethasone—ankylosing spondylitis	0.000179	0.00112	CcSEcCtD
Docetaxel—Insomnia—Triamcinolone—ankylosing spondylitis	0.000178	0.00112	CcSEcCtD
Docetaxel—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000178	0.00112	CcSEcCtD
Docetaxel—Infection—Dexamethasone—ankylosing spondylitis	0.000178	0.00111	CcSEcCtD
Docetaxel—Infection—Betamethasone—ankylosing spondylitis	0.000178	0.00111	CcSEcCtD
Docetaxel—TUBB4A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000178	0.00262	CbGpPWpGaD
Docetaxel—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000177	0.00111	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000177	0.00111	CcSEcCtD
Docetaxel—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000177	0.00111	CcSEcCtD
Docetaxel—Visual impairment—Methotrexate—ankylosing spondylitis	0.000177	0.00111	CcSEcCtD
Docetaxel—Anaemia—Prednisone—ankylosing spondylitis	0.000177	0.00111	CcSEcCtD
Docetaxel—Shock—Dexamethasone—ankylosing spondylitis	0.000176	0.0011	CcSEcCtD
Docetaxel—Shock—Betamethasone—ankylosing spondylitis	0.000176	0.0011	CcSEcCtD
Docetaxel—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000176	0.0011	CcSEcCtD
Docetaxel—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000176	0.0011	CcSEcCtD
Docetaxel—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000176	0.0011	CcSEcCtD
Docetaxel—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000175	0.0011	CcSEcCtD
Docetaxel—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000175	0.0011	CcSEcCtD
Docetaxel—Tachycardia—Betamethasone—ankylosing spondylitis	0.000175	0.00109	CcSEcCtD
Docetaxel—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000175	0.00109	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000174	0.00257	CbGpPWpGaD
Docetaxel—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000174	0.00109	CcSEcCtD
Docetaxel—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000173	0.00109	CcSEcCtD
Docetaxel—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000173	0.00109	CcSEcCtD
Docetaxel—Eye disorder—Methotrexate—ankylosing spondylitis	0.000171	0.00107	CcSEcCtD
Docetaxel—Syncope—Prednisone—ankylosing spondylitis	0.000171	0.00107	CcSEcCtD
Docetaxel—KIF11—Immune System—HLA-A—ankylosing spondylitis	0.000171	0.00252	CbGpPWpGaD
Docetaxel—Anorexia—Betamethasone—ankylosing spondylitis	0.000171	0.00107	CcSEcCtD
Docetaxel—Anorexia—Dexamethasone—ankylosing spondylitis	0.000171	0.00107	CcSEcCtD
Docetaxel—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00017	0.00107	CcSEcCtD
Docetaxel—Fatigue—Triamcinolone—ankylosing spondylitis	0.00017	0.00107	CcSEcCtD
Docetaxel—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00017	0.00106	CcSEcCtD
Docetaxel—Pain—Triamcinolone—ankylosing spondylitis	0.000169	0.00106	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000168	0.00105	CcSEcCtD
Docetaxel—Hypotension—Betamethasone—ankylosing spondylitis	0.000167	0.00105	CcSEcCtD
Docetaxel—Hypotension—Dexamethasone—ankylosing spondylitis	0.000167	0.00105	CcSEcCtD
Docetaxel—Angiopathy—Methotrexate—ankylosing spondylitis	0.000166	0.00104	CcSEcCtD
Docetaxel—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000166	0.00104	CcSEcCtD
Docetaxel—Convulsion—Prednisone—ankylosing spondylitis	0.000166	0.00104	CcSEcCtD
Docetaxel—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000165	0.00104	CcSEcCtD
Docetaxel—Hypertension—Prednisone—ankylosing spondylitis	0.000165	0.00103	CcSEcCtD
Docetaxel—Chills—Methotrexate—ankylosing spondylitis	0.000165	0.00103	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000163	0.00102	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000163	0.00102	CcSEcCtD
Docetaxel—KIF11—Immune System—CRP—ankylosing spondylitis	0.000163	0.0024	CbGpPWpGaD
Docetaxel—Myalgia—Prednisone—ankylosing spondylitis	0.000163	0.00102	CcSEcCtD
Docetaxel—Arthralgia—Prednisone—ankylosing spondylitis	0.000163	0.00102	CcSEcCtD
Docetaxel—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000163	0.00102	CcSEcCtD
Docetaxel—TUBB4B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000163	0.0024	CbGpPWpGaD
Docetaxel—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000162	0.00102	CcSEcCtD
Docetaxel—Alopecia—Methotrexate—ankylosing spondylitis	0.000162	0.00102	CcSEcCtD
Docetaxel—Insomnia—Betamethasone—ankylosing spondylitis	0.000162	0.00101	CcSEcCtD
Docetaxel—Insomnia—Dexamethasone—ankylosing spondylitis	0.000162	0.00101	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000162	0.00101	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000161	0.00101	CcSEcCtD
Docetaxel—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000161	0.00101	CcSEcCtD
Docetaxel—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000161	0.00101	CcSEcCtD
Docetaxel—Mental disorder—Methotrexate—ankylosing spondylitis	0.000161	0.00101	CcSEcCtD
Docetaxel—Malnutrition—Methotrexate—ankylosing spondylitis	0.00016	0.001	CcSEcCtD
Docetaxel—Erythema—Methotrexate—ankylosing spondylitis	0.00016	0.001	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000159	0.00235	CbGpPWpGaD
Docetaxel—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000158	0.00099	CcSEcCtD
Docetaxel—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000158	0.000987	CcSEcCtD
Docetaxel—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000158	0.000987	CcSEcCtD
Docetaxel—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000156	0.000979	CcSEcCtD
Docetaxel—KIF11—Immune System—TLR4—ankylosing spondylitis	0.000156	0.0023	CbGpPWpGaD
Docetaxel—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000156	0.000977	CcSEcCtD
Docetaxel—Oedema—Prednisone—ankylosing spondylitis	0.000156	0.000977	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000156	0.000977	CcSEcCtD
Docetaxel—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000156	0.000975	CcSEcCtD
Docetaxel—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000156	0.000975	CcSEcCtD
Docetaxel—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000156	0.000975	CcSEcCtD
Docetaxel—Infection—Prednisone—ankylosing spondylitis	0.000155	0.00097	CcSEcCtD
Docetaxel—BCL2—Apoptosis—TNF—ankylosing spondylitis	0.000155	0.00228	CbGpPWpGaD
Docetaxel—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000155	0.000968	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000155	0.000968	CcSEcCtD
Docetaxel—Back pain—Methotrexate—ankylosing spondylitis	0.000154	0.000967	CcSEcCtD
Docetaxel—Fatigue—Dexamethasone—ankylosing spondylitis	0.000154	0.000967	CcSEcCtD
Docetaxel—Fatigue—Betamethasone—ankylosing spondylitis	0.000154	0.000967	CcSEcCtD
Docetaxel—MAPT—Apoptosis—TNF—ankylosing spondylitis	0.000154	0.00227	CbGpPWpGaD
Docetaxel—Shock—Prednisone—ankylosing spondylitis	0.000153	0.000961	CcSEcCtD
Docetaxel—Pain—Betamethasone—ankylosing spondylitis	0.000153	0.000959	CcSEcCtD
Docetaxel—Pain—Dexamethasone—ankylosing spondylitis	0.000153	0.000959	CcSEcCtD
Docetaxel—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000153	0.000958	CcSEcCtD
Docetaxel—Tachycardia—Prednisone—ankylosing spondylitis	0.000152	0.000953	CcSEcCtD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000152	0.00224	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000152	0.00224	CbGpPWpGaD
Docetaxel—Skin disorder—Prednisone—ankylosing spondylitis	0.000151	0.000949	CcSEcCtD
Docetaxel—EGFR—B Cell Activation—CD79A—ankylosing spondylitis	0.00015	0.00222	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1R2—ankylosing spondylitis	0.00015	0.00221	CbGpPWpGaD
Docetaxel—Anorexia—Prednisone—ankylosing spondylitis	0.000149	0.000931	CcSEcCtD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000148	0.00218	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000148	0.00218	CbGpPWpGaD
Docetaxel—Anaemia—Methotrexate—ankylosing spondylitis	0.000148	0.000924	CcSEcCtD
Docetaxel—EGFR—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.000148	0.00218	CbGpPWpGaD
Docetaxel—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000148	0.000924	CcSEcCtD
Docetaxel—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000148	0.000924	CcSEcCtD
Docetaxel—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000146	0.000917	CcSEcCtD
Docetaxel—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000146	0.000917	CcSEcCtD
Docetaxel—EGFR—Immune System—KIR3DL1—ankylosing spondylitis	0.000146	0.00215	CbGpPWpGaD
Docetaxel—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000145	0.000911	CcSEcCtD
Docetaxel—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000145	0.000909	CcSEcCtD
Docetaxel—MAPT—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000144	0.00213	CbGpPWpGaD
Docetaxel—Leukopenia—Methotrexate—ankylosing spondylitis	0.000143	0.000895	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000142	0.00089	CcSEcCtD
Docetaxel—Dizziness—Prednisolone—ankylosing spondylitis	0.000142	0.000889	CcSEcCtD
Docetaxel—BCL2—Immune System—ERAP1—ankylosing spondylitis	0.000142	0.00209	CbGpPWpGaD
Docetaxel—Asthenia—Triamcinolone—ankylosing spondylitis	0.000142	0.000887	CcSEcCtD
Docetaxel—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000142	0.000887	CcSEcCtD
Docetaxel—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000142	0.000887	CcSEcCtD
Docetaxel—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000142	0.000887	CcSEcCtD
Docetaxel—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000142	0.000887	CcSEcCtD
Docetaxel—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000141	0.000885	CcSEcCtD
Docetaxel—Insomnia—Prednisone—ankylosing spondylitis	0.000141	0.000883	CcSEcCtD
Docetaxel—Paraesthesia—Prednisone—ankylosing spondylitis	0.00014	0.000877	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—HLA-C—ankylosing spondylitis	0.00014	0.00206	CbGpPWpGaD
Docetaxel—Pruritus—Triamcinolone—ankylosing spondylitis	0.00014	0.000874	CcSEcCtD
Docetaxel—Cough—Methotrexate—ankylosing spondylitis	0.000139	0.000873	CcSEcCtD
Docetaxel—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000139	0.000872	CcSEcCtD
Docetaxel—EGFR—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000139	0.00205	CbGpPWpGaD
Docetaxel—Convulsion—Methotrexate—ankylosing spondylitis	0.000138	0.000866	CcSEcCtD
Docetaxel—EGFR—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000138	0.00204	CbGpPWpGaD
Docetaxel—Dyspepsia—Prednisone—ankylosing spondylitis	0.000137	0.00086	CcSEcCtD
Docetaxel—Chest pain—Methotrexate—ankylosing spondylitis	0.000136	0.000851	CcSEcCtD
Docetaxel—Arthralgia—Methotrexate—ankylosing spondylitis	0.000136	0.000851	CcSEcCtD
Docetaxel—Myalgia—Methotrexate—ankylosing spondylitis	0.000136	0.000851	CcSEcCtD
Docetaxel—Decreased appetite—Prednisone—ankylosing spondylitis	0.000136	0.000849	CcSEcCtD
Docetaxel—Rash—Prednisolone—ankylosing spondylitis	0.000135	0.000847	CcSEcCtD
Docetaxel—Dermatitis—Prednisolone—ankylosing spondylitis	0.000135	0.000847	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000135	0.000846	CcSEcCtD
Docetaxel—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000135	0.000844	CcSEcCtD
Docetaxel—Fatigue—Prednisone—ankylosing spondylitis	0.000134	0.000842	CcSEcCtD
Docetaxel—Headache—Prednisolone—ankylosing spondylitis	0.000134	0.000842	CcSEcCtD
Docetaxel—Constipation—Prednisone—ankylosing spondylitis	0.000133	0.000835	CcSEcCtD
Docetaxel—EGFR—Innate Immune System—CARD9—ankylosing spondylitis	0.000132	0.00194	CbGpPWpGaD
Docetaxel—Confusional state—Methotrexate—ankylosing spondylitis	0.000131	0.000823	CcSEcCtD
Docetaxel—Dizziness—Triamcinolone—ankylosing spondylitis	0.00013	0.000817	CcSEcCtD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.00013	0.00192	CbGpPWpGaD
Docetaxel—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00013	0.000816	CcSEcCtD
Docetaxel—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00013	0.000815	CcSEcCtD
Docetaxel—BCL2—Immune System—CARD9—ankylosing spondylitis	0.00013	0.00191	CbGpPWpGaD
Docetaxel—Infection—Methotrexate—ankylosing spondylitis	0.000129	0.000811	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000128	0.000805	CcSEcCtD
Docetaxel—Asthenia—Betamethasone—ankylosing spondylitis	0.000128	0.000805	CcSEcCtD
Docetaxel—Asthenia—Dexamethasone—ankylosing spondylitis	0.000128	0.000805	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000128	0.00189	CbGpPWpGaD
Docetaxel—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000128	0.0008	CcSEcCtD
Docetaxel—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000128	0.000799	CcSEcCtD
Docetaxel—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000127	0.000799	CcSEcCtD
Docetaxel—Nausea—Prednisolone—ankylosing spondylitis	0.000127	0.000798	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000127	0.00188	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000127	0.00188	CbGpPWpGaD
Docetaxel—Pruritus—Dexamethasone—ankylosing spondylitis	0.000127	0.000793	CcSEcCtD
Docetaxel—Pruritus—Betamethasone—ankylosing spondylitis	0.000127	0.000793	CcSEcCtD
Docetaxel—Skin disorder—Methotrexate—ankylosing spondylitis	0.000127	0.000793	CcSEcCtD
Docetaxel—EGFR—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000126	0.00186	CbGpPWpGaD
Docetaxel—Vomiting—Triamcinolone—ankylosing spondylitis	0.000125	0.000786	CcSEcCtD
Docetaxel—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000125	0.000784	CcSEcCtD
Docetaxel—Rash—Triamcinolone—ankylosing spondylitis	0.000124	0.000779	CcSEcCtD
Docetaxel—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000124	0.000779	CcSEcCtD
Docetaxel—Anorexia—Methotrexate—ankylosing spondylitis	0.000124	0.000778	CcSEcCtD
Docetaxel—Rash—Methylprednisolone—ankylosing spondylitis	0.000124	0.000778	CcSEcCtD
Docetaxel—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000124	0.000777	CcSEcCtD
Docetaxel—Headache—Triamcinolone—ankylosing spondylitis	0.000124	0.000774	CcSEcCtD
Docetaxel—Headache—Methylprednisolone—ankylosing spondylitis	0.000123	0.000773	CcSEcCtD
Docetaxel—Abdominal pain—Prednisone—ankylosing spondylitis	0.000123	0.000772	CcSEcCtD
Docetaxel—Body temperature increased—Prednisone—ankylosing spondylitis	0.000123	0.000772	CcSEcCtD
Docetaxel—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000122	0.000767	CcSEcCtD
Docetaxel—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000122	0.000767	CcSEcCtD
Docetaxel—Hypotension—Methotrexate—ankylosing spondylitis	0.000122	0.000763	CcSEcCtD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000122	0.00179	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000121	0.00179	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00012	0.00178	CbGpPWpGaD
Docetaxel—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000119	0.000744	CcSEcCtD
Docetaxel—Dizziness—Betamethasone—ankylosing spondylitis	0.000118	0.000742	CcSEcCtD
Docetaxel—Dizziness—Dexamethasone—ankylosing spondylitis	0.000118	0.000742	CcSEcCtD
Docetaxel—Insomnia—Methotrexate—ankylosing spondylitis	0.000118	0.000738	CcSEcCtD
Docetaxel—Nausea—Triamcinolone—ankylosing spondylitis	0.000117	0.000734	CcSEcCtD
Docetaxel—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000117	0.000733	CcSEcCtD
Docetaxel—Nausea—Methylprednisolone—ankylosing spondylitis	0.000117	0.000732	CcSEcCtD
Docetaxel—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000116	0.000728	CcSEcCtD
Docetaxel—Somnolence—Methotrexate—ankylosing spondylitis	0.000116	0.000726	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000115	0.00072	CcSEcCtD
Docetaxel—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000115	0.000718	CcSEcCtD
Docetaxel—Vomiting—Dexamethasone—ankylosing spondylitis	0.000114	0.000713	CcSEcCtD
Docetaxel—Vomiting—Betamethasone—ankylosing spondylitis	0.000114	0.000713	CcSEcCtD
Docetaxel—GHRHR—Signaling Pathways—MMP3—ankylosing spondylitis	0.000113	0.00167	CbGpPWpGaD
Docetaxel—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000113	0.00071	CcSEcCtD
Docetaxel—Rash—Dexamethasone—ankylosing spondylitis	0.000113	0.000707	CcSEcCtD
Docetaxel—Rash—Betamethasone—ankylosing spondylitis	0.000113	0.000707	CcSEcCtD
Docetaxel—Dermatitis—Betamethasone—ankylosing spondylitis	0.000113	0.000706	CcSEcCtD
Docetaxel—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000113	0.000706	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000112	0.000705	CcSEcCtD
Docetaxel—Fatigue—Methotrexate—ankylosing spondylitis	0.000112	0.000704	CcSEcCtD
Docetaxel—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000112	0.00166	CbGpPWpGaD
Docetaxel—Headache—Betamethasone—ankylosing spondylitis	0.000112	0.000703	CcSEcCtD
Docetaxel—Headache—Dexamethasone—ankylosing spondylitis	0.000112	0.000703	CcSEcCtD
Docetaxel—Asthenia—Prednisone—ankylosing spondylitis	0.000112	0.000701	CcSEcCtD
Docetaxel—Pain—Methotrexate—ankylosing spondylitis	0.000111	0.000698	CcSEcCtD
Docetaxel—Pruritus—Prednisone—ankylosing spondylitis	0.00011	0.000691	CcSEcCtD
Docetaxel—ABCC1—Disease—ANTXR2—ankylosing spondylitis	0.000108	0.0016	CbGpPWpGaD
Docetaxel—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000107	0.000673	CcSEcCtD
Docetaxel—Diarrhoea—Prednisone—ankylosing spondylitis	0.000107	0.000668	CcSEcCtD
Docetaxel—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000107	0.000667	CcSEcCtD
Docetaxel—Nausea—Dexamethasone—ankylosing spondylitis	0.000106	0.000666	CcSEcCtD
Docetaxel—Nausea—Betamethasone—ankylosing spondylitis	0.000106	0.000666	CcSEcCtD
Docetaxel—Dizziness—Prednisone—ankylosing spondylitis	0.000103	0.000646	CcSEcCtD
Docetaxel—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000103	0.000645	CcSEcCtD
Docetaxel—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000103	0.000645	CcSEcCtD
Docetaxel—EGFR—Disease—ANTXR2—ankylosing spondylitis	0.000102	0.00151	CbGpPWpGaD
Docetaxel—Vomiting—Prednisone—ankylosing spondylitis	9.91e-05	0.000621	CcSEcCtD
Docetaxel—Rash—Prednisone—ankylosing spondylitis	9.83e-05	0.000616	CcSEcCtD
Docetaxel—Dermatitis—Prednisone—ankylosing spondylitis	9.82e-05	0.000615	CcSEcCtD
Docetaxel—Headache—Prednisone—ankylosing spondylitis	9.77e-05	0.000612	CcSEcCtD
Docetaxel—Hypersensitivity—Methotrexate—ankylosing spondylitis	9.6e-05	0.000601	CcSEcCtD
Docetaxel—BCL2—Apoptosis—TNF—ankylosing spondylitis	9.47e-05	0.0014	CbGpPWpGaD
Docetaxel—Asthenia—Methotrexate—ankylosing spondylitis	9.35e-05	0.000586	CcSEcCtD
Docetaxel—Nausea—Prednisone—ankylosing spondylitis	9.26e-05	0.00058	CcSEcCtD
Docetaxel—Pruritus—Methotrexate—ankylosing spondylitis	9.22e-05	0.000577	CcSEcCtD
Docetaxel—Diarrhoea—Methotrexate—ankylosing spondylitis	8.91e-05	0.000558	CcSEcCtD
Docetaxel—EGFR—Immune System—IL1R2—ankylosing spondylitis	8.85e-05	0.0013	CbGpPWpGaD
Docetaxel—Dizziness—Methotrexate—ankylosing spondylitis	8.62e-05	0.00054	CcSEcCtD
Docetaxel—EGFR—Immune System—ERAP1—ankylosing spondylitis	8.39e-05	0.00124	CbGpPWpGaD
Docetaxel—Vomiting—Methotrexate—ankylosing spondylitis	8.28e-05	0.000519	CcSEcCtD
Docetaxel—BCL2—Innate Immune System—HLA-B—ankylosing spondylitis	8.27e-05	0.00122	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HLA-C—ankylosing spondylitis	8.27e-05	0.00122	CbGpPWpGaD
Docetaxel—Rash—Methotrexate—ankylosing spondylitis	8.22e-05	0.000515	CcSEcCtD
Docetaxel—Dermatitis—Methotrexate—ankylosing spondylitis	8.21e-05	0.000514	CcSEcCtD
Docetaxel—Headache—Methotrexate—ankylosing spondylitis	8.16e-05	0.000511	CcSEcCtD
Docetaxel—BCL2—Immune System—HLA-C—ankylosing spondylitis	8.15e-05	0.0012	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	8.02e-05	0.00118	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-C—ankylosing spondylitis	7.94e-05	0.00117	CbGpPWpGaD
Docetaxel—Nausea—Methotrexate—ankylosing spondylitis	7.74e-05	0.000485	CcSEcCtD
Docetaxel—EGFR—Immune System—CARD9—ankylosing spondylitis	7.67e-05	0.00113	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—B3GNT2—ankylosing spondylitis	7.57e-05	0.00112	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CRP—ankylosing spondylitis	7.31e-05	0.00108	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1RN—ankylosing spondylitis	7.08e-05	0.00104	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—TLR4—ankylosing spondylitis	7.01e-05	0.00103	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TNF—ankylosing spondylitis	6.97e-05	0.00103	CbGpPWpGaD
Docetaxel—ABCC1—Disease—B3GNT2—ankylosing spondylitis	6.39e-05	0.000942	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD79A—ankylosing spondylitis	6.21e-05	0.000916	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD79A—ankylosing spondylitis	6.06e-05	0.000893	CbGpPWpGaD
Docetaxel—EGFR—Disease—B3GNT2—ankylosing spondylitis	6.02e-05	0.000888	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—B3GNT2—ankylosing spondylitis	5.35e-05	0.000789	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—ankylosing spondylitis	5.25e-05	0.000774	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—B3GNT2—ankylosing spondylitis	5.18e-05	0.000763	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1A—ankylosing spondylitis	5.09e-05	0.000751	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD40LG—ankylosing spondylitis	5.07e-05	0.000747	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.94e-05	0.000728	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.9e-05	0.000722	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HLA-B—ankylosing spondylitis	4.89e-05	0.000721	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	4.85e-05	0.000715	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-B—ankylosing spondylitis	4.82e-05	0.00071	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-C—ankylosing spondylitis	4.82e-05	0.00071	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.74e-05	0.000699	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	4.71e-05	0.000694	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.7e-05	0.000693	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	4.67e-05	0.000688	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-A—ankylosing spondylitis	4.46e-05	0.000658	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-A—ankylosing spondylitis	4.35e-05	0.000642	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CRP—ankylosing spondylitis	4.32e-05	0.000637	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CRP—ankylosing spondylitis	4.26e-05	0.000628	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1RN—ankylosing spondylitis	4.18e-05	0.000617	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR4—ankylosing spondylitis	4.14e-05	0.000611	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR4—ankylosing spondylitis	4.08e-05	0.000602	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD79A—ankylosing spondylitis	3.67e-05	0.000542	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MMP3—ankylosing spondylitis	3.49e-05	0.000514	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	3.37e-05	0.000497	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1A—ankylosing spondylitis	3.01e-05	0.000444	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD40LG—ankylosing spondylitis	2.99e-05	0.000442	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTGER4—ankylosing spondylitis	2.89e-05	0.000427	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-B—ankylosing spondylitis	2.85e-05	0.00042	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-A—ankylosing spondylitis	2.64e-05	0.000389	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HLA-A—ankylosing spondylitis	2.59e-05	0.000381	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	2.55e-05	0.000375	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CRP—ankylosing spondylitis	2.52e-05	0.000371	CbGpPWpGaD
Docetaxel—EGFR—Disease—HLA-A—ankylosing spondylitis	2.44e-05	0.000359	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR4—ankylosing spondylitis	2.41e-05	0.000356	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	2.39e-05	0.000353	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—ankylosing spondylitis	2.22e-05	0.000327	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP3—ankylosing spondylitis	2.06e-05	0.000304	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.57e-05	0.000231	CbGpPWpGaD
